Global Biopsy Forceps & Polypectomy Snares Market Size, Share, and Trends Analysis - Global - 2026-2032 - Includes: Biopsy Forceps, Polypectomy Snares, and 1 more
Description
Global Biopsy Forceps & Polypectomy Snares Market Report, 2025 Edition
Executive Summary
The global biopsy forceps and polypectomy snare market was valued at approximately $472 million in 2025. The market is expected to grow at a compound annual growth rate (CAGR) of 2.3%, reaching over $553 million by 2032.
This report covers biopsy forceps and polypectomy snares used in gastrointestinal endoscopy for tissue sampling and polyp removal. It quantifies unit sales, average selling prices (ASPs), market values, growth rates, and company shares, and analyzes market drivers, limiters, recent mergers and acquisitions, and technology trends. It provides historical data from 2022 to 2024 and forecasts to 2032.
The scope reflects how the increasing adoption of disposable devices, the expansion of colorectal cancer screening programs, and procedural shifts toward cold snaring are shaping the global biopsy forceps and polypectomy snare markets.
Market Overview
Biopsy forceps and polypectomy snares are among the most frequently used accessories in gastrointestinal endoscopy. They play an essential role in diagnosing and removing lesions, polyps, and abnormal tissue from the digestive tract.
Over the past decade, this market has experienced notable changes driven by technological evolution, regulatory updates, and global health trends. While unit volumes have expanded significantly, pricing dynamics have remained under pressure as hospitals and ambulatory endoscopy centers adopt cost-effective single-use products.
Following a sharp drop in pricing several years ago, the biopsy forceps segment saw a strong rebound in unit sales. The affordability of disposable devices encouraged more frequent use, which in turn supported total market value despite reduced margins for manufacturers. By 2025, price erosion had slowed, and a more stable pricing environment allowed for steady revenue growth.
In parallel, the polypectomy snare segment has benefited from increasing clinical preference for cold snaring in small polyp removal procedures. This trend has strengthened demand for snares, especially as global colorectal cancer screening programs expand.
The combined market continues to evolve as procedure volumes grow, device usage patterns shift toward single-use models, and training improvements make advanced polypectomy techniques more accessible to physicians worldwide. While competitive pricing and declining reusable device adoption constrain overall value growth, the market remains poised for moderate and sustained expansion through 2032.
Market Drivers
Disposable Forcep
Disposable biopsy forceps have become the preferred choice in most healthcare settings. After the steep price drop seen in earlier years, disposable forceps became much more accessible to hospitals and clinics. The lower cost continues to encourage frequent use, increasing unit volumes worldwide.
Although reduced pricing has narrowed manufacturer margins, total revenues are still rising as procedure volumes increase. With only modest price declines projected over the coming years, unit sales will remain the main contributor to market expansion. This steady shift toward disposables has also been supported by regulatory and infection-control measures discouraging reusable device use in certain regions.
As manufacturers focus on improving design reliability and cutting-edge jaw mechanisms, the disposable segment is expected to strengthen its dominance within the global biopsy forceps market.
Increase in Colorectal Cancer Screening
Colonoscopy remains one of the highest-volume endoscopic procedures worldwide. As of 2025, global initiatives promoting early detection of colorectal cancer have expanded significantly, particularly in North America, Europe, and parts of Asia-Pacific.
Rising participation in screening programs is directly increasing the number of biopsy and polypectomy procedures, thereby boosting demand for both forceps and snares. The aging population in many developed regions is further driving this trend, as older adults represent the highest-risk group for colorectal cancer.
Ongoing awareness campaigns and the inclusion of screening in national health guidelines have made colorectal cancer prevention a key public health priority. As a result, the need for endoscopic tools such as biopsy forceps and polypectomy snares will continue to grow over the forecast period.
Cold Snaring Technique
Historically, small polyps under 8 millimeters were removed using biopsy forceps. However, the cold snaring technique, which uses a non-electrified snare to excise small polyps with better margin clearance, is becoming the standard of care in many practices.
The technique reduces the risk of thermal injury to the mucosa, improves completeness of resection, and shortens procedure time. As adoption increases, demand for polypectomy snares is expected to rise steadily.
This procedural shift represents a key driver for market growth, as it expands snare utilization beyond larger lesions into smaller, more common cases. Manufacturers are responding with product designs that offer better control, thinner wires, and improved shape memory for enhanced precision.
Market Limiters
Shift from Forceps to Snaring
The widespread adoption of cold snaring for small polyps is a double-edged factor for the market. While it benefits snare demand, it has also contributed to a decline in biopsy forceps usage for certain indications. As physicians increasingly favor snares for complete resections, forceps utilization in these smaller cases continues to fall.
This trend is particularly evident in countries where clinical guidelines recommend cold snaring over biopsy for small polyp removal. The shift is expected to constrain the growth potential of the biopsy forceps segment over time.
Technical Challenges
Despite its clinical benefits, snaring presents higher technical difficulty compared to forceps use. Flat or sessile polyps that lie close to the intestinal wall are harder to capture, and successful retrieval of resected polyps can be inconsistent. Studies have reported retrieval failure rates near 16 percent, which underscores the need for continued training and refinement of snare designs.
While experienced endoscopists can overcome these challenges, they remain a limiting factor for broader procedural adoption, particularly in facilities with less experienced staff.
Decline in Reusable Devices
The market for reusable biopsy forceps continues to decline rapidly. These instruments are more expensive than disposable versions and carry risks of cross-contamination if reprocessed improperly. Regulatory measures in several regions have accelerated this transition. For example, the United Kingdom has implemented restrictions that prohibit the use of reusable forceps in clinical settings.
This shift has constrained overall market value, as reusable devices contribute higher revenue per unit. Although disposables now dominate the market, their lower price points limit total market growth despite higher volumes.
Market Coverage and Data Scope
Quantitative Coverage
Market size, shares, and forecasts
Growth rates, units sold, and average selling prices
Qualitative Coverage
Market growth trends and limiters
Competitive analysis and SWOT for top competitors
Mergers and acquisitions, company profiles, and product portfolios
FDA recalls and disruptive technology developments
Disease overview and procedure data influencing demand
Time Frame
Base year: 2025
Forecasts: 2026–2032
Historical data: 2022–2024
Data Sources
Primary interviews with endoscopists, industry experts, and market executives, supplemented by hospital procurement data, import and export databases, and iData Research’s internal database.
Method Note
Revenue estimates are modeled from units multiplied by ASP, validated against procedure numbers, utilization patterns, and replacement cycles by region.
Markets Covered and Segmentation
Biopsy Forceps & Polypectomy Snare Market – Further Segmented Into:
Biopsy Forceps
Polypectomy Snares
Competitive Analysis
Boston Scientific was the market leader in 2025, holding nearly half of the global biopsy forceps and polypectomy snare market. The company’s success is largely attributed to the strength of its Radial Jaw product line, which remains one of the most widely used forceps families globally. Boston Scientific’s consistent investment in product innovation and global distribution has solidified its leadership position across multiple regions.
Olympus Corporation maintained its presence through a portfolio of reusable biopsy forceps and snares. However, as demand for reusables continues to decline, Olympus has experienced gradual share erosion in recent years. The company remains most competitive in markets where reusable devices are still preferred, such as select European and Asian countries.
Cook Medical ranked as the third-largest competitor in the global market. The company offers a comprehensive product range that includes Captura Pro Biopsy Forceps, Captura Disposable Hot Biopsy Forceps, and Captura Mini Biopsy Forceps. Within the snare segment, Cook markets the AcuSnare Polypectomy Snare and its AcuSnare Duck Bill variant, known for their performance in capturing small and difficult polyps.
Overall, the market remains moderately consolidated, with these three manufacturers controlling the majority of global revenue. Smaller regional firms compete primarily in localized markets, often focusing on cost-competitive disposable offerings.
Technology and Practice Trends
The shift toward disposable biopsy forceps is now the dominant global trend, driven by infection prevention policies and lower reprocessing costs.
Cold snaring is replacing hot snaring and forceps resection for smaller polyps due to improved safety and margin clearance.
Single-use designs continue to improve in quality, offering comparable performance to reusable instruments at a fraction of the cost.
Ergonomic handles and improved jaw geometry are being introduced to enhance precision and reduce operator fatigue during extended procedures.
Training and procedural standardization efforts are increasing worldwide as endoscopy societies promote safe polypectomy and cold snare techniques.
Regulatory shifts in favor of disposables and infection control compliance continue to drive purchasing decisions in hospitals and clinics.
Geography
This edition provides complete global coverage, including data for North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
Why This Report
Where are the largest and fastest-growing opportunities within the global biopsy forceps and polypectomy snare market
How are pricing trends and disposable adoption shaping revenue growth across regions
What are the key risks and challenges, including declining reusable device sales and price competition
How will colorectal cancer screening programs influence demand for forceps and snares over the next decade
Which manufacturers are leading, and how are they positioning their product portfolios to compete globally
What technological and procedural shifts are redefining physician preferences in biopsy and polypectomy
The Global Biopsy Forceps & Polypectomy Snares Market Report from iData Research answers these questions with procedure-aware models, company share data, and price trend analysis. Use it to evaluate opportunities, benchmark performance, and plan product strategies in one of the most essential accessory markets in gastrointestinal endoscopy.
About iData Research
iData Research is a premium market intelligence firm headquartered in Canada with offices across North America and Europe.
Over the last 20 years, the company has specialized in device-level sizing, procedure models, pricing trends, and competitive share across MedTech.
Since 2005, iData has supported global OEMs, mid-market innovators, and investors with triangulated data based on units and ASPs, with country-level forecasts and analyst access across Europe, North America, Latin America, the Middle East, Africa, and APAC.
Reports are available with flexible licensing to fit commercial, strategy, and investment workflows
Executive Summary
The global biopsy forceps and polypectomy snare market was valued at approximately $472 million in 2025. The market is expected to grow at a compound annual growth rate (CAGR) of 2.3%, reaching over $553 million by 2032.
This report covers biopsy forceps and polypectomy snares used in gastrointestinal endoscopy for tissue sampling and polyp removal. It quantifies unit sales, average selling prices (ASPs), market values, growth rates, and company shares, and analyzes market drivers, limiters, recent mergers and acquisitions, and technology trends. It provides historical data from 2022 to 2024 and forecasts to 2032.
The scope reflects how the increasing adoption of disposable devices, the expansion of colorectal cancer screening programs, and procedural shifts toward cold snaring are shaping the global biopsy forceps and polypectomy snare markets.
Market Overview
Biopsy forceps and polypectomy snares are among the most frequently used accessories in gastrointestinal endoscopy. They play an essential role in diagnosing and removing lesions, polyps, and abnormal tissue from the digestive tract.
Over the past decade, this market has experienced notable changes driven by technological evolution, regulatory updates, and global health trends. While unit volumes have expanded significantly, pricing dynamics have remained under pressure as hospitals and ambulatory endoscopy centers adopt cost-effective single-use products.
Following a sharp drop in pricing several years ago, the biopsy forceps segment saw a strong rebound in unit sales. The affordability of disposable devices encouraged more frequent use, which in turn supported total market value despite reduced margins for manufacturers. By 2025, price erosion had slowed, and a more stable pricing environment allowed for steady revenue growth.
In parallel, the polypectomy snare segment has benefited from increasing clinical preference for cold snaring in small polyp removal procedures. This trend has strengthened demand for snares, especially as global colorectal cancer screening programs expand.
The combined market continues to evolve as procedure volumes grow, device usage patterns shift toward single-use models, and training improvements make advanced polypectomy techniques more accessible to physicians worldwide. While competitive pricing and declining reusable device adoption constrain overall value growth, the market remains poised for moderate and sustained expansion through 2032.
Market Drivers
Disposable Forcep
Disposable biopsy forceps have become the preferred choice in most healthcare settings. After the steep price drop seen in earlier years, disposable forceps became much more accessible to hospitals and clinics. The lower cost continues to encourage frequent use, increasing unit volumes worldwide.
Although reduced pricing has narrowed manufacturer margins, total revenues are still rising as procedure volumes increase. With only modest price declines projected over the coming years, unit sales will remain the main contributor to market expansion. This steady shift toward disposables has also been supported by regulatory and infection-control measures discouraging reusable device use in certain regions.
As manufacturers focus on improving design reliability and cutting-edge jaw mechanisms, the disposable segment is expected to strengthen its dominance within the global biopsy forceps market.
Increase in Colorectal Cancer Screening
Colonoscopy remains one of the highest-volume endoscopic procedures worldwide. As of 2025, global initiatives promoting early detection of colorectal cancer have expanded significantly, particularly in North America, Europe, and parts of Asia-Pacific.
Rising participation in screening programs is directly increasing the number of biopsy and polypectomy procedures, thereby boosting demand for both forceps and snares. The aging population in many developed regions is further driving this trend, as older adults represent the highest-risk group for colorectal cancer.
Ongoing awareness campaigns and the inclusion of screening in national health guidelines have made colorectal cancer prevention a key public health priority. As a result, the need for endoscopic tools such as biopsy forceps and polypectomy snares will continue to grow over the forecast period.
Cold Snaring Technique
Historically, small polyps under 8 millimeters were removed using biopsy forceps. However, the cold snaring technique, which uses a non-electrified snare to excise small polyps with better margin clearance, is becoming the standard of care in many practices.
The technique reduces the risk of thermal injury to the mucosa, improves completeness of resection, and shortens procedure time. As adoption increases, demand for polypectomy snares is expected to rise steadily.
This procedural shift represents a key driver for market growth, as it expands snare utilization beyond larger lesions into smaller, more common cases. Manufacturers are responding with product designs that offer better control, thinner wires, and improved shape memory for enhanced precision.
Market Limiters
Shift from Forceps to Snaring
The widespread adoption of cold snaring for small polyps is a double-edged factor for the market. While it benefits snare demand, it has also contributed to a decline in biopsy forceps usage for certain indications. As physicians increasingly favor snares for complete resections, forceps utilization in these smaller cases continues to fall.
This trend is particularly evident in countries where clinical guidelines recommend cold snaring over biopsy for small polyp removal. The shift is expected to constrain the growth potential of the biopsy forceps segment over time.
Technical Challenges
Despite its clinical benefits, snaring presents higher technical difficulty compared to forceps use. Flat or sessile polyps that lie close to the intestinal wall are harder to capture, and successful retrieval of resected polyps can be inconsistent. Studies have reported retrieval failure rates near 16 percent, which underscores the need for continued training and refinement of snare designs.
While experienced endoscopists can overcome these challenges, they remain a limiting factor for broader procedural adoption, particularly in facilities with less experienced staff.
Decline in Reusable Devices
The market for reusable biopsy forceps continues to decline rapidly. These instruments are more expensive than disposable versions and carry risks of cross-contamination if reprocessed improperly. Regulatory measures in several regions have accelerated this transition. For example, the United Kingdom has implemented restrictions that prohibit the use of reusable forceps in clinical settings.
This shift has constrained overall market value, as reusable devices contribute higher revenue per unit. Although disposables now dominate the market, their lower price points limit total market growth despite higher volumes.
Market Coverage and Data Scope
Quantitative Coverage
Market size, shares, and forecasts
Growth rates, units sold, and average selling prices
Qualitative Coverage
Market growth trends and limiters
Competitive analysis and SWOT for top competitors
Mergers and acquisitions, company profiles, and product portfolios
FDA recalls and disruptive technology developments
Disease overview and procedure data influencing demand
Time Frame
Base year: 2025
Forecasts: 2026–2032
Historical data: 2022–2024
Data Sources
Primary interviews with endoscopists, industry experts, and market executives, supplemented by hospital procurement data, import and export databases, and iData Research’s internal database.
Method Note
Revenue estimates are modeled from units multiplied by ASP, validated against procedure numbers, utilization patterns, and replacement cycles by region.
Markets Covered and Segmentation
Biopsy Forceps & Polypectomy Snare Market – Further Segmented Into:
Biopsy Forceps
Polypectomy Snares
Competitive Analysis
Boston Scientific was the market leader in 2025, holding nearly half of the global biopsy forceps and polypectomy snare market. The company’s success is largely attributed to the strength of its Radial Jaw product line, which remains one of the most widely used forceps families globally. Boston Scientific’s consistent investment in product innovation and global distribution has solidified its leadership position across multiple regions.
Olympus Corporation maintained its presence through a portfolio of reusable biopsy forceps and snares. However, as demand for reusables continues to decline, Olympus has experienced gradual share erosion in recent years. The company remains most competitive in markets where reusable devices are still preferred, such as select European and Asian countries.
Cook Medical ranked as the third-largest competitor in the global market. The company offers a comprehensive product range that includes Captura Pro Biopsy Forceps, Captura Disposable Hot Biopsy Forceps, and Captura Mini Biopsy Forceps. Within the snare segment, Cook markets the AcuSnare Polypectomy Snare and its AcuSnare Duck Bill variant, known for their performance in capturing small and difficult polyps.
Overall, the market remains moderately consolidated, with these three manufacturers controlling the majority of global revenue. Smaller regional firms compete primarily in localized markets, often focusing on cost-competitive disposable offerings.
Technology and Practice Trends
The shift toward disposable biopsy forceps is now the dominant global trend, driven by infection prevention policies and lower reprocessing costs.
Cold snaring is replacing hot snaring and forceps resection for smaller polyps due to improved safety and margin clearance.
Single-use designs continue to improve in quality, offering comparable performance to reusable instruments at a fraction of the cost.
Ergonomic handles and improved jaw geometry are being introduced to enhance precision and reduce operator fatigue during extended procedures.
Training and procedural standardization efforts are increasing worldwide as endoscopy societies promote safe polypectomy and cold snare techniques.
Regulatory shifts in favor of disposables and infection control compliance continue to drive purchasing decisions in hospitals and clinics.
Geography
This edition provides complete global coverage, including data for North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
Why This Report
Where are the largest and fastest-growing opportunities within the global biopsy forceps and polypectomy snare market
How are pricing trends and disposable adoption shaping revenue growth across regions
What are the key risks and challenges, including declining reusable device sales and price competition
How will colorectal cancer screening programs influence demand for forceps and snares over the next decade
Which manufacturers are leading, and how are they positioning their product portfolios to compete globally
What technological and procedural shifts are redefining physician preferences in biopsy and polypectomy
The Global Biopsy Forceps & Polypectomy Snares Market Report from iData Research answers these questions with procedure-aware models, company share data, and price trend analysis. Use it to evaluate opportunities, benchmark performance, and plan product strategies in one of the most essential accessory markets in gastrointestinal endoscopy.
About iData Research
iData Research is a premium market intelligence firm headquartered in Canada with offices across North America and Europe.
Over the last 20 years, the company has specialized in device-level sizing, procedure models, pricing trends, and competitive share across MedTech.
Since 2005, iData has supported global OEMs, mid-market innovators, and investors with triangulated data based on units and ASPs, with country-level forecasts and analyst access across Europe, North America, Latin America, the Middle East, Africa, and APAC.
Reports are available with flexible licensing to fit commercial, strategy, and investment workflows
Table of Contents
89 Pages
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
